» Articles » PMID: 39513907

Mechanism of Marinobufagenin-Induced Hyperpermeability of Human Brain Microvascular Endothelial Cell Monolayer: A Potential Pathogenesis of Seizure in Preeclampsia

Overview
Journal Cells
Publisher MDPI
Date 2024 Nov 8
PMID 39513907
Authors
Affiliations
Soon will be listed here.
Abstract

Preeclampsia (preE) is a hypertensive disorder in pregnancies. It is the third leading cause of mortality among pregnant women and fetuses worldwide, and there is much we have yet to learn about its pathophysiology. One complication includes cerebral edema, which causes a breach of the blood-brain barrier (BBB). Urinary marinobufagenin (MBG) is elevated in a preE rat model prior to developing hypertension and proteinuria. We investigated what effect MBG has on the endothelial cell permeability of the BBB. Human brain microvascular endothelial cells (HBMECs) were utilized to examine the permeability caused by MBG. The phosphorylation of ERK1/2, Jnk, p38, and Src was evaluated after the treatment with MBG. Apoptosis was evaluated by examining caspase 3/7. MBG ≥ 1 nM inhibited the proliferation of HBMECs by 46-50%. MBG induced monolayer permeability, causing a decrease in the phosphorylation of ERK1/2 and the activated phosphorylation of Jnk, p38, and Src. MBG increased the caspase 3/7 expression, indicating the activation of apoptosis. Apoptotic signaling or the disruption of endothelia tight junction proteins was not observed when using the p38 inhibitor as a pretreatment in MBG-treated cells. The MBG-induced enhancement of the HBMEC monolayer permeability occurs by the downregulation of ERK1/2, the activation of Jnk, p38, Src, and apoptosis, resulting in the cleavage of tight junction proteins, and are attenuated by p38 inhibition.

References
1.
Carrozzino F, Pugnale P, Feraille E, Montesano R . Inhibition of basal p38 or JNK activity enhances epithelial barrier function through differential modulation of claudin expression. Am J Physiol Cell Physiol. 2009; 297(3):C775-87. DOI: 10.1152/ajpcell.00084.2009. View

2.
Agunanne E, Horvat D, Harrison R, Uddin M, Jones R, Kuehl T . Marinobufagenin levels in preeclamptic patients: a preliminary report. Am J Perinatol. 2011; 28(7):509-14. DOI: 10.1055/s-0031-1272965. View

3.
Roberts J, Taylor R, Musci T, Rodgers G, Hubel C, McLaughlin M . Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989; 161(5):1200-4. DOI: 10.1016/0002-9378(89)90665-0. View

4.
Bartal M, Sibai B . Eclampsia in the 21st century. Am J Obstet Gynecol. 2020; 226(2S):S1237-S1253. DOI: 10.1016/j.ajog.2020.09.037. View

5.
Schoner W, Scheiner-Bobis G . Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer. Semin Nephrol. 2005; 25(5):343-51. DOI: 10.1016/j.semnephrol.2005.03.010. View